alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
H. Res. 774

In the House of Representatives, U.S., 

April 26, 2006.

Resolved, That at any time after the adoption of this resolution the Speaker may, pursuant to clause 2(b) of rule 

XVIII, declare the House resolved into the Committee of the 

Whole House on the state of the Union for consideration of 

the bill (H.R. 5020) to authorize appropriations for fiscal 

year 2007 for intelligence and intelligence-related activities of 

the United States Government, the Community Management 

Account, and the Central Intelligence Agency Retirement and 

Disability System, and for other purposes. The first reading 

of the bill shall be dispensed with. All points of order against 

consideration of the bill are waived. General debate shall be 

confined to the bill and shall not exceed one hour equally divided and controlled by the chairman and ranking minority 

member of the Permanent Select Committee on Intelligence. 

After general debate the bill shall be considered for amendment under the five-minute rule. It shall be in order to consider as an original bill for the purpose of amendment under 

the five-minute rule the amendment in the nature of a sub-
2

•HRES 774 EH 

stitute recommended by the Permanent Select Committee on 

Intelligence now printed in the bill. The committee amendment in the nature of a substitute shall be considered as 

read. All points of order against the committee amendment 

in the nature of a substitute are waived. Notwithstanding 

clause 11 of rule XVIII, no amendment to the committee 

amendment in the nature of a substitute shall be in order except those printed in the report of the Committee on Rules 

accompanying this resolution. Each such amendment may be 

offered only in the order printed in the report, may be offered 

only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the 

report equally divided and controlled by the proponent and an 

opponent, shall not be subject to amendment, and shall not 

be subject to a demand for division of the question in the 

House or in the Committee of the Whole. All points of order 

against such amendments are waived. At the conclusion of 

consideration of the bill for amendment the Committee shall 

rise and report the bill to the House with such amendments 

as may have been adopted. Any Member may demand a separate vote in the House on any amendment adopted in the 

Committee of the Whole to the bill or to the committee 

amendment in the nature of a substitute. The previous question shall be considered as ordered on the bill and amend-
3

•HRES 774 EH 

ments thereto to final passage without intervening motion except one motion to recommit with or without instructions. 

Attest:

Clerk.
### Re: Today ' s call Dan Bivins Dan Bivins to: Jeff Ryan 10/04/2012 09:42 AM Cc: Sarah Marshall, Charles Hall, David Ogulei, Kim Garnett
This is a response from a question to Pall about their HAP Metals CEMS probe.
Dan,
Lilly didn't request a transport system with their Xact 640 purchase. We were asked to modify our stilling chamber to subsample from a PM CEMS transport system from Europe. CES sold 3 other Xact 640 systems (1- 2004, 2-2007) all to the US Army. I designed and installed the transports systems for each of those units. We made a lot of progress on our transport design between 04 and 07. Larry Wells in Tooele, UT was real happy with the changes he saw with his 2007 installation.
Pall has partnered with the major probe supplier for the CAMR Hg CEMS installs back in 2009. We co-developed a probe to meet our specific needs and have taken delivery of that transport system for the Xact 645 (Hg CEMS). This will be our standard offering for meeting PS-12 A

. The Xact 640 Multi-Metals CEMS transport builds on the information learned by CES. The Pall fluid dynamics team has tested two systems on CFPP for multi-metals. This is our HAP Metals CEMS transport systems for EGU MAT and any other compliance application for multiple metals .
We are in the process of collecting the 30 days of continuous data testing our HAP Metals CEMS Performance Specification. Connie Sue requested this data for the broadly approved application of our CEMS. We would appreciate your feed back on our HAP Metals CEMS PS to meet the EGU MAT alternative monitoring approach. As I told Connie Sue at the ICAC meeting we will have this PS to you this Fall.
Regards,
Douglas C. Barth Pall Corporation Power Generation Group Business Development Manager Emissions Monitoring Products 2118 Greenspring Dr. Timonium, MD 21093 cell: 860-576-2409 Jeff Ryan 10/02/2012 12:05:09 PM How about I handle the Pall call and you guys...

From: Jeff Ryan/RTP/USEPA/US To: Sarah Marshall/R5/USEPA/US@EPA Cc: Charles Hall/R5/USEPA/US@EPA, Dan Bivins/RTP/USEPA/US@EPA, David

Ogulei/R5/USEPA/US@EPA, Kim Garnett/RTP/USEPA/US@EPA Date: 10/02/2012 12:05 PM Subject: Re: Today's call
How about I handle the Pall call and you guys handle the Evonik call?
#### THE UNITED STATES v. AMMEN FARENHOLT.

[Not reported in C. Cls. R.; 206 U. S. R., 226.]

*On the*defendants’ *Appeal.*

Claimant brought suit in the Court of Claims to recover from the United States the sum of $282.66 for the difference, he alleged, he was entitled to as a passed assistant surgeon in the Navy, with the rank of lieutenant, for mounted pay from December 26, 1900, to July 27, 1901, with 10 per cent increase for service outside the limits of the United States.

The court below found the facts without an opinion and the claimant was given judgment for $141.33 on the authority of the case of *Richardson*v. *The United States.*(38 C. Cls. R,., 182.) The 10 per cent increase was not allowed.-

The judgment of the court below is affirmed on the same grounds.

*536May 13, 1907.

Mr. Justice McKenna

.delivered the opinion of the Supreme Court
# EUR-Lex - 31991D0552 - EN

Avis juridique important

*|*

# 31991D0552

**91/552/EEC: Commission Decision of 27 September 1991 establishing the status of Denmark as regards Newcastle disease **

*
Official Journal L 298 , 29/10/1991 P. 0021 - 0021 *

COMMISSION DECISION of 27 September 1991 establishing the status of Denmark as regards Newcastle disease (91/552/EEC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Directive 90/593/EEC of 15 October 1990 on animal health conditions governing intra-Communnity trade in and imports from third countries of poultry and hatching eggs (1), and in particular Article 12 (2) thereof,

Whereas no outbreaks of Newcastle disease have been detected and vaccination against Newcastle disease in poultry has been prohibited for over a year in Denmark;

Whereas breeding flocks in Denmark have been monitored at least once a year for the presence of Newcastle disease; whereas the holdings contain no poultry which have been vaccinated against Newcastle disease;

Whereas in the light of the Newcastle disease situation it is not yet appropriate to fix the status of other Member States;

Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,

HAS ADOPTED THIS DECISION:

Article 1

Denmark fulfils the criteria fixed by Article 12 (2) of Directive 90/539/EEC.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 27 September 1991.

For the Commission Ray MAC SHARRY Member of the Commission

(1) OJ N° L 303, 31. 10. 1991, p. 6.
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 1214 Introduced in Senate (IS)]

<DOC>

115th CONGRESS
  1st Session
                                S. 1214

 To amend the Toxic Substances Control Act to clarify the jurisdiction 
of the Environmental Protection Agency with respect to certain sporting 
  good articles, and to exempt those articles from a definition under 
                               that Act.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 24, 2017

  Mr. Thune (for himself and Ms. Klobuchar) introduced the following 
bill; which was read twice and referred to the Committee on Environment 
                            and Public Works

_______________________________________________________________________

                                 A BILL

 
 To amend the Toxic Substances Control Act to clarify the jurisdiction 
of the Environmental Protection Agency with respect to certain sporting 
  good articles, and to exempt those articles from a definition under 
                               that Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Hunting, Fishing, and Recreational 
Shooting Protection Act''.

SEC. 2. MODIFICATION OF DEFINITION.

    Section 3(2)(B) of the Toxic Substances Control Act (15 U.S.C. 
2602(2)(B)) is amended--
            (1) in clause (v), by striking ``, and'' and inserting ``, 
        or any component of any such article including, without 
        limitation, shot, bullets and other projectiles, propellants, 
        and primers,'';
            (2) in clause (vi) by striking the period at the end and 
        inserting ``, and''; and
            (3) by inserting after clause (vi) the following:
            ``(vii) any sport fishing equipment (as such term is 
        defined in section 4162(a) of the Internal Revenue Code of 
        1986) the sale of which is subject to the tax imposed by 
        section 4161(a) of such Code (determined without regard to any 
        exemptions from such tax provided by section 4162 or 4221 or 
        any other provision of such Code), and sport fishing equipment 
        components.''.
                                 <all>
```
###### Editorial Note on Part 12

#### Editorial Note:

Nomenclature changes to part 12 appear at 88 FR 45064, July 14, 2023.

#### § 12.26 Modification or revocation of regulation or order.

If the Commissioner determines upon review of an objection or request for hearing that the regulation or order should be modified or revoked, the Commissioner will promptly take such action by notice in the Federal Register. Further objections to or requests for hearing on the modification or revocation may be submitted under §§ 12.20 through 12.22 but no further issue may be taken with other provisions in the regulation or order. Objections and requests for hearing that are not affected by the modification or revocation will remain on file and be acted upon in due course.
================================================================================

EXHIBIT 32.2

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection  with the Quarterly  Report of CirTran  Corporation on Form 10-QSB
for the period  ending  September  30, 2006,  as filed with the  Securities  and
Exchange  Commission on the date hereof (the "Report"),  Richard Ferrone,  Chief
Financial Officer of the Company, certifies, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)      The Report fully  complies  with the  requirements  of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

(2)      The  information  contained  in  the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.

November 20, 2006

                                             /s/ Richard Ferrone
                                            -------------------------------
                                            Richard Ferrone
                                            Chief Financial Officer
















--------------------------------------------------------------------------------
#### § 111.65 What are the requirements for quality control operations?

You must implement quality control operations in your manufacturing, packaging, labeling, and holding operations for producing the dietary supplement to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record.
1

In The

Court of Appeals

Ninth District of Texas at Beaumont

____________________

NO. 09-15-00439-CR

NO. 09-15-00440-CR

NO. 09-15-00441-CR

____________________

TYLER LEBLANC, Appellant

V.

THE STATE OF TEXAS, Appellee

_______________________________________________________ ______________

On Appeal from the 356th District Court

Hardin County, Texas

Trial Cause Nos. 22768, 22770, and 22772

________________________________________________________ _____________

MEMORANDUM OPINION 

The trial court sentenced Tyler LeBlanc on November 17, 2014. The trial 

court signed certifications in which the court certified that these are plea-bargained

cases and the defendant has no right of appeal. See Tex. R. App. P. 25.2(a)(2).

LeBlanc filed a notice of appeal on October 30, 2015. We notified the parties that 

LeBlanc filed his notice of appeal too late to perfect an appeal. See Tex. R. App. P. 

25.2(b). The notice of appeal at issue here was filed after LeBlanc’s convictions 
2

were final, and LeBlanc’s three convictions are no longer subject to direct appeals. 

LeBlanc failed to establish that his notice of appeal was timely filed or that the 

Texas Court of Criminal Appeals granted an out-of-time appeal. See generally Tex. 

R. App. P. 73. 

The Court finds that the notice of appeal was not timely filed. See Tex. R.

App. P. 26.2. No motion for extension of time was timely filed pursuant to Tex. R.

App. P. 26.3. Furthermore, we must dismiss the appeals because the trial court’s 

certifications show the defendant does not have the right of appeal. See Tex. R. 

App. P. 25.2(d). We dismiss the appeals. 

APPEALS DISMISSED.

 ________________________________

 HOLLIS HORTON

 Justice

 

Submitted on November 24, 2015

Opinion Delivered November 25, 2015

Do Not Publish

Before Kreger, Horton, and Johnson, JJ.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Balance
Sheet, Statement of Operations, Statements of Cash Flows and Notes thereto
incorporated in Part I, Item 1 of this Form 10-QSB and is qualified in its
entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        16,400
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-BASIC>                                     0.00
<EPS-DILUTED>                                     0.00


</TABLE>
#### § 1309.21 Persons required to register.

(a) Unless exempted by law or under [§§ 1309.24](/on/2024-09-17/title-21/section-1309.24) through [1309.26](/on/2024-09-17/title-21/section-1309.26) or [§§ 1310.12](/on/2024-09-17/title-21/section-1310.12) through [1310.13 of this chapter](/on/2024-09-17/title-21/section-1310.13), the following persons must annually obtain a registration specific to the List I chemicals to be handled:

(1) Every person who manufactures or imports or proposes to manufacture or import a List I chemical or a drug product containing ephedrine, pseudoephedrine, or phenylpropanolamine.

(2) Every person who distributes or exports or proposes to distribute or export any List I chemical, other than those List I chemicals contained in a product exempted under paragraph (1)(iv) of the definition of regulated transaction in [§ 1300.02 of this chapter](/on/2024-09-17/title-21/section-1300.02).

(b) Only persons actually engaged in the activities are required to obtain a registration; related or affiliated persons who are not engaged in the activities are not required to be registered. (For example, a stockholder or parent corporation of a corporation distributing List I chemicals is not required to obtain a registration.)

(c) The registration requirements are summarized in the following table:

Summary of Registration Requirements and Limitations

| Business activity | Chemicals | DEA forms | Application fee | Registration period (years) | Coincident activities allowed |
| --- | --- | --- | --- | --- | --- |
| (1) Manufacturing | List I, Drug products containing ephedrine, pseudoephedrine, phenylpropanolamine | New-510 Renewal-510a | 3,699 | 1 | May distribute that chemical for which registration was issued; may not distribute any chemical for which not registered. |
| (2) Distributing | List I, Scheduled listed chemical products | New-510 Renewal-510a | 1,850 | 1 | |
| (3) Importing | List I, Drug Products containing ephedrine, pseudoephedrine, phenylpropanolamine | New-510 Renewal-510a | 1,850 | 1 | May distribute that chemical for which registration was issued; may not distribute any chemical for which not registered. |
| (4) Exporting | List I, Scheduled listed chemical products | New-510 Renewal-510a | 1,850 | 1 | |

[[75 FR 4980](https://www.federalregister.gov/citation/75-FR-4980), Feb. 1, 2010, as amended at [77 FR 4236](https://www.federalregister.gov/citation/77-FR-4236), Jan. 27, 2012; [77 FR 15250](https://www.federalregister.gov/citation/77-FR-15250), Mar. 15, 2012; [85 FR 44734](https://www.federalregister.gov/citation/85-FR-44734), July 24, 2020]
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of The Topps Company, Inc. (the "Company") on Form 10-Q for the
period ended August 26, 2006, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Catherine K.
Jessup, Vice President-Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted
pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.



| | /s/ Catherine K. Jessup
                      Catherine K. JessupVice President, Chief Financial Officer and Treasurer
| | ----------------------------------------------------------------------------------------------------------------------

Date:  October 5, 2006

---
EXHIBIT 32

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of CirTran Corporation on Form 10-QSB/A
for the period ending March 31, 2004, as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), Iehab Hawatmeh, President and
Chief Financial Officer of the Company, certifies, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

(1)  The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and result of operations of the Company.

August 17, 2004
                                         /s/ Iehab Hawatmeh
                                       -----------------------------------
                                        Iehab J. Hawatmeh
                                        President and Chief Financial Officer
§ 782.20 Does this part apply to me? This part and, through this part, pertinent portions of the OMB guidance in subparts A through F of 2 CFR part 182 (see table at 2 CFR 182.115(b)) apply to you if you are a— ( a ) Recipient of a USAID grant or cooperative agreement; or
( b ) USAID awarding official.